AdaFusion is presented, a lightweight adaptive fusion framework that integrates complementary signals from multiple frozen PFMs through low-dimensional feature compression and a sample-conditioned gating module that reweights model-wise (and optionally channel-wise) contributions.
Abstract
Pathology foundation models (PFMs) provide strong tile-level representations via self-supervised pre-training on large-scale pathology images. Yet, PFMs are developed under diverse and often opaque data, architecture, and objective choices, inducing latent representational biases that limit robustness and obscure what each model specialises in. We present AdaFusion, a lightweight adaptive fusion framework that integrates complementary signals from multiple frozen PFMs through (1) low-dimensional feature compression and (2) a sample-conditioned gating module that reweights model-wise (and optionally channel-wise) contributions. Beyond improving predictive accuracy, AdaFusion provides contribution-driven interpretation that offers evidence consistent with model-specific preferences and synergistic interactions across tissue phenotypes. We evaluate AdaFusion on three public benchmarks spanning treatment response prediction, prostate cancer grading, and spatial gene expression inference. AdaFusion consistently outperforms individual PFMs and other fusion baselines, while providing interpretable tissue visualisation which aligns model preferences with morphological patterns. Code is available at: https://github.com/xyx-98/PathoOracle.
PRISM2 demonstrates how language-supervised pretraining provides a scalable, clinically grounded signal for generalizable pathology representations, bridging human diagnostic reasoning and foundation model performance.
E. Vorontsov, George Shaikovski, Adam Casson et al.· Nature Medicine· 3 citations
This work reports Pathway Activity Autoencoders for the multi-omics setting, which embed prior knowledge via pathway-informed architectural constraints, fostering interpretability, while preserving representational power, in the context of breast cancer.
Pedro Henrique da Costa Avelar, L. Ou-Yang, Min Wu et al.· 0 citations
A structure-aware deep learning framework that integrates species-level shotgun metagenomic profiles with mixed-type clinical covariates through view-specific encoders, clustering-informed contrastive alignment, and adaptive representation fusion, which provides a robust and interpretable framework for multi-view metag...
Lindong Jiang, Martha I Gonzalez-Ramirez, Kuan-Jui Su et al.· Research Square· 0 citations
OmicFormer, a Transformer-based architecture that embeds two complementary statistical priors, i.e., feature-label associations and feature-feature dependencies, directly into its representation learning, provides an interpretable and generalizable foundation for omics-based precision medicine.
H. Jiang, C. Yang, M. Qin et al.· medRxiv· 0 citations
Attention-based multiple instance learning (ABMIL) is the predominant approach for slide-level prediction in computational pathology, yet its attention maps provide only local explanations: they indicate where a model focuses but not which histological features drive its predictions or how the model behaves across a pa...
Abdallah Lamane, Abdul Rahman Diab, Ren-Chin Wu et al.· 0 citations
VirTues-derived biomarkers predict anti-PD-L1 chemo-immunotherapy response and stratify disease-free survival in an independent cohort, outperforming state-of-the-art biomarkers derived from the same datasets and current clinical stratification schemes.
Johann Wenckstern, Eeshaan Jain, Benedikt von Querfurth et al.· Nature· 4 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.